110 related articles for article (PubMed ID: 12959500)
1. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging.
Bigler ED; Lowry CM; Kerr B; Tate DF; Hessel CD; Earl HD; Miller MJ; Rice SA; Smith KH; Tschanz JT; Welsh-Bohmer K; Plassman B; Victoroff J
Neuropsychology; 2003 Jul; 17(3):339-52. PubMed ID: 12959500
[TBL] [Abstract][Full Text] [Related]
2. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia.
Bigler ED; Neeley ES; Miller MJ; Tate DF; Rice SA; Cleavinger H; Wolfson L; Tschanz J; Welsh-Bohmer K
J Int Neuropsychol Soc; 2004 May; 10(3):442-52. PubMed ID: 15147601
[TBL] [Abstract][Full Text] [Related]
3. White matter lesions, quantitative magnetic resonance imaging, and dementia.
Bigler ED; Kerr B; Victoroff J; Tate DF; Breitner JC
Alzheimer Dis Assoc Disord; 2002; 16(3):161-70. PubMed ID: 12218647
[TBL] [Abstract][Full Text] [Related]
4. Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment.
Bigler ED; Tate DF; Miller MJ; Rice SA; Hessel CD; Earl HD; Tschanz JT; Plassman B; Welsh-Bohmer KA
J Int Neuropsychol Soc; 2002 Nov; 8(7):925-33. PubMed ID: 12405544
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
7. The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis.
Scheltens NM; Galindo-Garre F; Pijnenburg YA; van der Vlies AE; Smits LL; Koene T; Teunissen CE; Barkhof F; Wattjes MP; Scheltens P; van der Flier WM
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):235-43. PubMed ID: 25783437
[TBL] [Abstract][Full Text] [Related]
8. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
[TBL] [Abstract][Full Text] [Related]
9. Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.
Łojkowska W; Witkowski G; Bednarska-Makaruk M; Wehr H; Sienkiewicz-Jarosz H; Graban A; Bochyńska A; Wiśniewska A; Gugała M; Sławińska K; Sawicka B; Poniatowska R; Ryglewicz D
Curr Alzheimer Res; 2013 Nov; 10(9):964-72. PubMed ID: 24117117
[TBL] [Abstract][Full Text] [Related]
10. [A neuroradiological study on the influence of cerebral atrophy and white matter lesion on cognitive function in the elderly].
Terai S
Nihon Ronen Igakkai Zasshi; 2004 Sep; 41(5):521-7. PubMed ID: 15515734
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
12. Dementia, quantitative neuroimaging, and apolipoprotein E genotype.
Bigler ED; Lowry CM; Anderson CV; Johnson SC; Terry J; Steed M
AJNR Am J Neuroradiol; 2000; 21(10):1857-68. PubMed ID: 11110538
[TBL] [Abstract][Full Text] [Related]
13. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype.
Bronge L; Fernaeus SE; Blomberg M; Ingelson M; Lannfelt L; Isberg B; Wahlund LO
Dement Geriatr Cogn Disord; 1999; 10(2):89-96. PubMed ID: 10026381
[TBL] [Abstract][Full Text] [Related]
14. Impact of APOE in mild cognitive impairment.
Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
[TBL] [Abstract][Full Text] [Related]
15. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
[TBL] [Abstract][Full Text] [Related]
16. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
17. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
Korf ES; Wahlund LO; Visser PJ; Scheltens P
Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
19. Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.
Wang Z; Dai Z; Shu H; Liu D; Guo Q; He Y; Zhang Z
J Alzheimers Dis; 2017; 56(1):415-428. PubMed ID: 27911306
[TBL] [Abstract][Full Text] [Related]
20. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.
Sawada H; Udaka F; Izumi Y; Nishinaka K; Kawakami H; Nakamura S; Kameyama M
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):653-6. PubMed ID: 10766901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
